Micron Technology, Inc.

  • ISIN: US5951121038
  • Land: .

Nachricht vom 30.03.2012 | 03:18

Micron Technology Settles Lawsuit With Oracle


Micron Technology, Inc. 

30.03.2012 03:18

BOISE, Idaho, 2012-03-30 03:18 CEST (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq:MU), announced today that it reached an agreement with Oracle America Inc. ('Oracle') to settle a lawsuit filed by Oracle against Micron in the U.S. District Court for the Northern District of California. The lawsuit alleged a conspiracy to increase DRAM prices and other violations of federal and state antitrust and unfair competition laws based on purported conduct for the period from Aug. 1, 1998, through at least June 15, 2002, and sought joint and several damages, trebled, as well as restitution, disgorgement, attorneys' fees, costs and injunctive relief. Pursuant to the settlement agreement, the parties agreed to a settlement and release of all claims and a dismissal with prejudice of the litigation. Under applicable accounting principles, the effect of this settlement on Micron's results of operations for the second fiscal quarter of 2012 is a reduction in revenue and an increase in the net loss attributable to Micron shareholders of $58 million as compared to the results previously reported on March 22, 2012, with corresponding adjustments to other items included in the company's results of operations. As a result, for the second quarter of fiscal 2012, Micron's net loss attributable to its shareholders was $282 million, or $0.29 per diluted share, on net sales of $2.009 billion. The full effect of the settlement on Micron's results of operations and financial position for the second quarter of fiscal 2012 will be provided in Micron's Form 10-Q. Micron Technology, Inc., is one of the world's leading providers of advanced semiconductor solutions. Through its worldwide operations, Micron manufactures and markets a full range of DRAM, NAND and NOR flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, embedded and mobile products. Micron's common stock is traded on the NASDAQ under the MU symbol. To learn more about Micron Technology, Inc., visit www.micron.com. The Micron Technology, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6950 CONTACT: Kipp A Bedard Investor Relations 1-208-368-4465 kbedard@micron.com Daniel Francisco Micron Technology, Inc. 1-208-368-5584 dfrancisco@micron.com News Source: NASDAQ OMX 30.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: Micron Technology, Inc. United States Phone: Fax: E-mail: Internet: ISIN: US5951121038 WKN: End of Announcement DGAP News-Service

GBC im Fokus

23. MKK – Münchner Kapitalmarkt Konferenz

Für: Institutionelle Investoren & Presse

Wann: 26. & 27. April 2017, 9 - 17 Uhr

Wo: The Charles Hotel - Rocco Forte Hotels, München

GBC im Fokus

Neovacs S.A.: Kursziel auf 3,30 € angehoben

In den letzten Monaten hatte die Neovacs S.A. einen positiven Newsflow. Im Vordergrund steht die Vertriebspartnerschaft für den chinesischen Markt, wodurch sich bis nach dem ersten Vermarktungsjahr Gesamterträge von bis zu 65 Mio. € ergeben können. Zudem verläuft der klinische Zulassungsprozess des IFNα-Kinoid zur Behandlung von SLE (Systemischer Lupus) und Dermatomyositis planmäßig. Wir haben in unsere Bewertung aktualisiert und ein Kursziel von 3,30 € je Aktie (bisher: 2,90 €) ermittelt. Das Rating lautet weiter KAUFEN.

News im Fokus

Bayerische Motoren Werke Aktiengesellschaft: Vorsteuerergebnis und Umsatz der BMW Group im ersten Quartal 2017 über Markterwartungen

20. April 2017, 12:11

Aktueller Webcast

Scout24 AG

Q1 Results 2017

10. Mai 2017

Aktuelle Research-Studie

Vita 34 AG

Original-Research: Vita 34 AG (von Montega AG): Kaufen

21. April 2017